Eli Lilly led a Stocktwits poll, with 32% support, ahead of Novo Nordisk, Hims & Hers Health and Viking Therapeutics at 16%. ...

Investing in pharmaceutical companies with robust product pipelines and diversified revenue streams is often considered a ...

Vital Stories, a new filmmaking initiative from Tribeca Studios and the pharmaceutical company Lilly, was announced on ...

The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss ...

Attorney General Dana Nessel’s ability to go after a major producer of insulin for price gouging was before the Michigan ...

Investing in pharmaceutical companies with diversified revenue bases and strong R&D pipelines could be a lucrative strategy.

A Delaware judge denied Pfizer's attempt to halt Metsera from accepting Novo Nordisk's $10 billion offer. Although Novo faces antitrust challenges, both companies are fiercely bidding for Metsera in a ...

Michigan Attorney General Dana Nessel's office is asking the court to overturn two previous rulings and allow an investigation into Eli Lilly and Co.

COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year forecasts on Wednesday as sales growth of its ...

The Trump administration is reportedly finalizing a deal with Eli Lilly and Novo Nordisk that would lower prices on Wegovy, ...

The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some ...

In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator, Kimberly-Clark’s $40 billion Kenvue deal, and more.